Accrued expenses and other current liabilities |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued expenses and other current liabilities | Accrued expenses and other current liabilities: Accrued expenses and other current liabilities are comprised of the following as of June 30, 2026 and December 31, 2025:
The majority of other accrued expenses and current liabilities relate to R&D consumables received by the Company but not yet billed by the suppliers.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||